Submitted by Anonymous (not verified) on 24 September 2024 - 12:36
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 14, Status: Authorised